New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

BioStem Technologies, Inc. (BSEM) vs Citius Pharmaceuticals, Inc. (CTXR)

BioStem Technologies, Inc. and Citius Pharmaceuticals, Inc. are both Biotechnology companies. BioStem Technologies, Inc. and Citius Pharmaceuticals, Inc. are of similar size ($13.7M and $13.6M). Citius Pharmaceuticals, Inc. has the higher net margin (0.00% vs −121.0%) and the lower return on invested capital (−58.7% vs −7.07%). Across the 8 metrics below, Citius Pharmaceuticals, Inc. leads on 5 and BioStem Technologies, Inc. on 3.

Valuation

Metric BSEM CTXR Biotechnology median
P/E n/m n/m 8.49
P/S 0.36 — 8.56
P/B 0.62 0.18 2.04
Price to free cash flow — n/m 23.84
EV/EBITDA n/m n/m 0.69
EV/Sales 0.33 — 8.00
Earnings yield (348.67%) (418.29%) (35.81%)
Free cash flow yield — (261.25%) (25.41%)

Profitability

Metric BSEM CTXR Biotechnology median
Gross margin 79.83% — 70.18%
Operating margin (6.18%) 0.00% 0.00%
Net margin (121.02%) 0.00% 0.00%
Free cash flow margin — 0.00% 0.00%
Return on equity — (64.51%) (51.58%)
Return on assets — (34.29%) (45.91%)
Return on invested capital (7.07%) (58.74%) 0.00%

Growth

Metric BSEM CTXR Biotechnology median
Revenue growth (TTM) (83.87%) — 7.20%
EPS growth (last fiscal year) (126.53%) 43.38% 29.04%
Revenue growth, 5-year CAGR — — 9.54%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric BSEM CTXR Biotechnology median
Debt to equity 0.00 0.08 0.00
Current ratio 0.73 0.84 4.79
Net debt to EBITDA — 0.11 1.01

Dividend

Metric BSEM CTXR Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BSEM CTXR Biotechnology median
Market cap 13.57m 13.65m 150.57m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack